The quest for human immortality

The Next Stage podcast by Web Summit

Web Summit에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Web Summit 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

1+ y ago 22:41

MP3•에피소드 홈

Beyond the indulgences of tech billionaires including Bryan Johnson – who has spent millions on longevity interventions (including plasma infusions from a teenage son) – can the rest of us expect to live into our hundreds?

Amol Sarva, founder of a venture fund investing in longevity research, and Joel Jackson, co-founder and president of a healthtech company trying to extend lifespans, discuss how tech advances including AI and personalised medicine could help extend life spans to 150 years or more.

Amol and Joel explore recent progress in targeting diseases of ageing, as well as fundamental biological ageing. While human immortality in 20 years seems unlikely, breakthroughs that slow the ageing process are possible. But ethical questions remain around fair access.

Amol Sarva, managing partner at Life Extension Ventures, and Joel Jackson, co-founder and president of Lifeforce, were in conversation with Yuliya Sotska, chief brand and communications officer for Viseven, on HealthConf at Collision 2023.

276 에피소드